Mitkovskaya N., Patejuk I. (2007) Bezbolevaya ishemiya miokarda: patofi ziologicheskie osobennosti, prognosticheskoe znachenie [Silent myocardial ischemia: pathophysiological features, prognostic value]. <...> Mitkovskaya N., Patejuk I., StatkevichT., Terekhov V., Shkrebneva E. (2015) Bezbolevaya ishemiya miokarda u patsientov s metabolicheskim sindromom: stratifi katsiya kardiovaskulyarnogo riska [Silent myocardial ischemia in patients with the metabolic syndrome: stratifi cation of cardiovascular risk]. <...> Университет Западного Онтарио, Лондонский медицинский научный центр, Лондон, Канада Current minimally-invasive treatment options for aortic stenosis Современные мини-инвазивные возможности лечения аортального стеноза ______________________ Abstract __________________________________________________________________________ Utilization of TAVI (transcatheter aortic valve implantation) has increased substantially over the past few years. <...> Careful planning of the procedure itself is a critical component of the patient selection and is of considerably importance in optimizing procedural and long-term outcoms. <...> The Heart «Кардиология в Беларуси» 2017, том 9, № 3 597 Современные мини-инвазивные возможности лечения аортального стеноза Team approach as well as comprehensive perioperative management and out-patient follow-up are essential for treatment options improvement. <...> The patient is placed on cardio-pulmonary bypass and the heart is arrested with cardioplegia. <...> This permits the surgeon to enter the aorta via an aortotomy incision, expose the valve from the superior aspect and excise the calcifi ed leafl ets. <...> An appropriately-sized new mechanical or bioprosthetic valve is anchored with sutures into the circumferential sewing ring and secured into place. <...> There are also new sutureless valves which can be inserted into this space through the same technique. <...> Since its introduction in 1960, this remained a major advance in cardiovascular medicine, reversing the precipitous decline, relieving symptomatology and improving survival in patients with symptomatic severe aortic stenosis. <...> The options for management of this condition changed on April 16th, 2002 when Dr. Alain Cribier performed the fi rst-in-man TAVI (transcatheter aortic valve implantation) procedure in Rouen, France [1]. <...> This revolutionary endeavour illustrated that a valve prosthesis can be inserted into the aortic position through an endovascular catheter-based approach. <...> Candidates for this procedure are those with symptomatic severe aortic stenosis of the native valve. <...> The application is somewhat of a moving target as we gain <...>